bioAffinity Technologies, Inc.
BIAF
$10.50
$1.5717.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.91% | -63.07% | -64.94% | -74.51% | -33.80% |
| Total Depreciation and Amortization | -27.85% | -23.88% | -16.63% | -10.99% | 12.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 82.10% | 303.78% | 352.83% | 369.62% | 103.96% |
| Change in Net Operating Assets | -126.49% | -78.41% | 230.66% | 417.78% | 572.62% |
| Cash from Operations | -49.42% | -66.36% | -28.41% | -17.25% | -9.22% |
| Capital Expenditure | -25.14% | 82.49% | 23.39% | 7.76% | -30.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -25.14% | 82.49% | 23.39% | 7.76% | 96.72% |
| Total Debt Issued | -- | -- | -- | -133.56% | 515.67% |
| Total Debt Repaid | 49.16% | 15.18% | -2.41% | 0.23% | -55.13% |
| Issuance of Common Stock | 52.29% | 139.26% | 110.30% | 244.96% | 262.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -40.42% | -131.06% | -40.42% | -141.37% | -- |
| Cash from Financing | 70.14% | 192.70% | 161.81% | 338.43% | 332.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108,366.67% | 232.12% | 411.40% | 284.20% | 100.02% |